Daktari Diagnostics, a developer of handheld HIV monitoring devices, has raised $7 million in a venture capital round, according to a new filing by the company with the Securities and Exchange Commission. 26 separate investors participated in the financing.

Daktari Diagnostics develops simple, accurate, and affordable products that address the most pressing challenges in global health. We are committed to delivering critical diagnostic test results to clinicians and patients across the globe.

Our team of engineers, scientists, physicians, and global health experts is uniquely dedicated to making high-performance products specifically designed for resource-poor markets.